While our findings of a correlation between sST2, Gal-3, and the CTR in CKD patients offer insights into the potential for these biomarkers in cardiovascular risk assessment, it is important to recognize the limitations of our study. The gene discussed is LGALS3; the disease is chronic kidney disease.